Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area stem cell stem gsk 3'

Search results for: 'research area stem cell stem gsk 3'

Items 11-20 of 47

Page
per page
  1. RG2833
    A3761 RG2833
    Target: HDAC
    Summary: Brain-penetrant HDAC inhibitor
      insoluble in H2O; ≥16.95 mg/mL
  2. Donepezil HCl
    B1602 Donepezil HCl
    Target: AChE
    Summary: AChE inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥10.4 mg/mL
  3. Apicidin
    A8176 Apicidin
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      soluble in DMSO or ethanol
  4. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  5. MLN8054
    A4114 MLN8054
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
  6. PF-03814735
    A4128 PF-03814735
    Target: Aurora Kinases
    Summary: Aurora A/B inhibitor
      Soluble in DMSO
  7. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  8. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  9. DMOG
    A4506 DMOG
    Target: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
    Summary: Competitive HIF-PH inhibitor, cell-permeable
  10. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    Target: FLT3|JAK|c-RET
    Summary: JAK-2 inhibitor,potent and selective
      ≥26.23 mg/mL

Items 11-20 of 47

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Aurora Kinase 9item
  2. DNA Methyltransferase 2item
  3. HDAC 16item
  4. Histone Acetyltransferases 3item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 3item
  7. HIF 1 item
  8. JAK 8item
  9. PARP 2item
  10. Protein Ser/Thr Phosphatases 1 item
  11. Sirtuin 2item
Specificity
  1. Selective 33item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 15item
  2. PI3K 1 item
  3. Aurora Kinases 10item
  4. EZH2 1 item
  5. FLT3 3item
  6. PLK 1 item
  7. VEGFR 3item
  8. Hydrolase 1 item
  9. DOT1L 1 item
  10. FGFR 2item
  11. Sir2-like Family Deacetylases (Sirtuins) 1 item
  12. PP1 1 item
  13. PP2A 1 item
  14. Src 2item
  15. Trk Receptors 1 item
  16. STAT 2item
  17. EGFR 1 item
  18. JAK 8item
  19. p300 1 item
  20. TNKS 1 item
  21. Topoisomerases 1 item
  22. DNA Methyltransferases 1 item
  23. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  24. PARP 1 item
  25. ALK 1 item
  26. MNK 1 item
  27. AChE 1 item
  28. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  29. PP4 1 item
  30. c-RET 1 item
  31. p53 1 item
  32. HDAC 1 item
  33. TYK2 1 item
  34. MUSK 1 item
  35. MAP3K 1 item
  36. p21 1 item
  37. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 4item
  3. Bladder Cancer 2item
  4. Breast Cancer 10item
  5. Cancer 32item
  6. Cervical Cancer 1 item
  7. Colon Cancer 5item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 2item
  10. Dyskinesia 1 item
  11. Friedreich's Ataxia 1 item
  12. Glioblastoma 1 item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 1 item
  15. Leukemia 2item
  16. Lung Cancer 3item
  17. Lymphoma 1 item
  18. Melanoma 2item
  19. Mixed Lineage Leukemia 1 item
  20. Multiple Myeloma 3item
  21. Myelofibrosis 1 item
  22. Non-small Cell Lung Cancer 2item
  23. Ovarian Cancer 1 item
  24. Prostate Cancer 7item
  25. Renal Cell Carcinoma 1 item
  26. Rheumatoid Arthritis 1 item